LifeVantage Corporation (NASDAQ: LFVN) Reports Declining Q4 FY2026 Financial Results Amidst Sales Drop

• LifeVantage Corporation (NASDAQ: LFVN) reported a 23.10% decrease in Q4 FY2026 revenue to $42.40 million, missing analyst expectations.
• The health and wellness company also saw its adjusted earnings per share (EPS) drop to $0.11, narrowly missing the consensus estimate of $0.12.
• Despite the declining sales and earnings, LifeVantage Corporation maintains a stable financial position with a low debt-to-equity ratio of 0.29.

LifeVantage Corporation (NASDAQ: LFVN) is a health and wellness company that develops and sells nutritional supplements and personal care products. The company recently announced its financial results for the fourth fiscal quarter, which ended on June 30, 2026. These results show a period of declining sales and earnings compared to the previous year.

The company's revenue for the quarter was $42.40 million, falling short of analyst expectations of $44.00 million. This represents a 23.10% decrease from the $55.10 million reported in the same period last year. As highlighted by GlobeNewswire, this decline was seen across its major markets, with a 24.80% drop in the Americas and a 16.90% decrease in Asia/Pacific and Europe.

According to its earnings call transcript published by Seeking Alpha, the revenue drop is due to fewer orders and smaller average order sizes. The results also faced a difficult comparison against strong prior-year sales of its MindBody GLP-1 System. For the full fiscal year 2026, LifeVantage Corporation reported total revenue of $182.60 million, a 20.10% decrease from the prior year.

LifeVantage Corporation reported an adjusted earnings per share (EPS) of $0.11, which narrowly missed the consensus estimate of $0.12. EPS is a measure of a company's profit allocated to each share of stock. This figure is down from $0.17 in the prior-year quarter, showing a reduction in profitability. Adjusted EBITDA, another measure of profit, also fell to $2.70 million from $4.80 million.

Despite the weaker results, the company's financial health shows some stability. LifeVantage Corporation has a debt-to-equity ratio of 0.29, which indicates it uses less debt than equity to finance its assets. Its price-to-earnings (P/E) ratio, which helps value a company's stock price relative to its earnings, stands at 16.13.